High-Density Amplicon Sequencing Identifies Community Spread and Ongoing Evolution of SARS-CoV-2 in the Southern United States.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
03 11 2020
Historique:
received: 16 06 2020
revised: 04 09 2020
accepted: 14 10 2020
pubmed: 29 10 2020
medline: 13 11 2020
entrez: 28 10 2020
Statut: ppublish

Résumé

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is constantly evolving. Prior studies focused on high-case-density locations, such as the northern and western metropolitan areas of the United States. This study demonstrates continued SARS-CoV-2 evolution in a suburban southern region of the United States by high-density amplicon sequencing of symptomatic cases. 57% of strains carry the spike D614G variant, which is associated with higher genome copy numbers, and its prevalence expands with time. Four strains carry a deletion in a predicted stem loop of the 3' UTR. The data are consistent with community spread within local populations and the larger continental United States. The data instill confidence in current testing sensitivity and validate "testing by sequencing" as an option to uncover cases, particularly nonstandard coronavirus disease 2019 (COVID-19) clinical presentations. This study contributes to the understanding of COVID-19 through an extensive set of genomes from a non-urban setting and informs vaccine design by defining D614G as a dominant and emergent SARS-CoV-2 isolate in the United States.

Identifiants

pubmed: 33113345
pii: S2211-1247(20)31341-3
doi: 10.1016/j.celrep.2020.108352
pmc: PMC7574689
pii:
doi:

Substances chimiques

Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108352

Subventions

Organisme : NCI NIH HHS
ID : P01 CA019014
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016086
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA239583
Pays : United States

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests M.B.M. serves on the advisory boards for Curetis, Luminex Molecular Diagnostics, Cepheid, BioFire Diagnostics, and QIAGEN and as a consultant to Shield Diagnostics.

Références

Mol Biol Evol. 1987 Jul;4(4):406-25
pubmed: 3447015
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
J Virol. 2020 Mar 17;94(7):
pubmed: 31996437
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
Euro Surveill. 2020 Apr;25(13):
pubmed: 32265007
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Nature. 2020 Jun;582(7813):561-565
pubmed: 32365353
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Int J Infect Dis. 2020 Oct;99:40-46
pubmed: 32721529
Emerg Microbes Infect. 2020 Dec;9(1):1287-1299
pubmed: 32525765
Proc Natl Acad Sci U S A. 2004 Jul 27;101(30):11030-5
pubmed: 15258291
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
Infect Genet Evol. 2020 Sep;83:104351
pubmed: 32387564
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Nucleic Acids Res. 2005 Nov 27;33(21):e182
pubmed: 16314296
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
J Virol. 2004 Jan;78(2):669-82
pubmed: 14694098
Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20166-71
pubmed: 22135472
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Clin Infect Dis. 2020 Jul 28;71(15):793-798
pubmed: 32221523
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Science. 2004 Mar 12;303(5664):1666-9
pubmed: 14752165
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Emerg Infect Dis. 2020 Aug;26(8):1935-1937
pubmed: 32392125
J Med Virol. 2020 May;92(5):522-528
pubmed: 32027036
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Virol. 1999 Oct;73(10):8349-55
pubmed: 10482585
Nat Med. 2020 Apr;26(4):450-452
pubmed: 32284615
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Mol Biol. 2020 May 1;432(10):3309-3325
pubmed: 32320687
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426
pubmed: 32271728
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Nat Med. 2020 Jun;26(6):845-848
pubmed: 32350462
Int J Infect Dis. 2020 Jul;96:459-460
pubmed: 32464271
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Emerg Infect Dis. 2020 Aug;26(8):1842-1845
pubmed: 32459984
Sci Rep. 2020 Aug 20;10(1):14031
pubmed: 32820179
Influenza Other Respir Viruses. 2020 Jul;14(4):465-469
pubmed: 32153113
J Med Virol. 2020 Sep;92(9):1637-1640
pubmed: 32222993
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9241-9243
pubmed: 32269081
J Virol. 2008 Feb;82(3):1214-28
pubmed: 18032506
Nature. 2020 May;581(7807):221-224
pubmed: 32225175
mBio. 2018 Mar 6;9(2):
pubmed: 29511076
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Int J Clin Pract. 2020 Aug;74(8):e13525
pubmed: 32374903
Front Oncol. 2019 Sep 04;9:851
pubmed: 31552176
Nat Microbiol. 2020 Apr;5(4):562-569
pubmed: 32094589
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
BMC Bioinformatics. 2010 Jul 20;11:386
pubmed: 20646303
Cell. 2020 May 28;181(5):990-996.e5
pubmed: 32386545
Cell Host Microbe. 2020 May 13;27(5):704-709.e2
pubmed: 32259477
Emerg Infect Dis. 2020 Aug;26(8):
pubmed: 32396505
Lancet. 2020 Jun 6;395(10239):1771-1778
pubmed: 32410760
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
Clin Infect Dis. 2020 Jul 28;71(15):799-806
pubmed: 32271376
Cell. 2020 Sep 3;182(5):1284-1294.e9
pubmed: 32730807
Nat Med. 2012 Dec;18(12):1820-6
pubmed: 23142821
Genes Dis. 2020 Dec;7(4):567-577
pubmed: 32837981
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
N Engl J Med. 2020 May 21;382(21):2012-2022
pubmed: 32227758
Cell. 2020 May 28;181(5):997-1003.e9
pubmed: 32359424
Commun Biol. 2018 Oct 29;1:179
pubmed: 30393776
Nat Med. 2020 Apr;26(4):502-505
pubmed: 32284613
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
Nature. 2020 Jul;583(7816):437-440
pubmed: 32434211

Auteurs

Ryan P McNamara (RP)

Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA.

Carolina Caro-Vegas (C)

Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA.

Justin T Landis (JT)

Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA.

Razia Moorad (R)

Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA.

Linda J Pluta (LJ)

Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA.

Anthony B Eason (AB)

Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA.

Cecilia Thompson (C)

Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Clinical Microbiology Laboratory, UNC Medical Center, Chapel Hill, NC 27599, USA.

Aubrey Bailey (A)

Kuopio Center for Gene and Cell Therapy, Kuopio, Finland.

Femi Cleola S Villamor (FCS)

Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA.

Philip T Lange (PT)

Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA.

Jason P Wong (JP)

Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA.

Tischan Seltzer (T)

Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA.

Jedediah Seltzer (J)

Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA.

Yijun Zhou (Y)

Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA.

Wolfgang Vahrson (W)

Basel, Switzerland.

Angelica Juarez (A)

Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA.

James O Meyo (JO)

Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Genetics Curriculum, Chapel Hill, NC 27599, USA.

Tiphaine Calabre (T)

École supérieure de Chimie Physique Électronique (CPE), Lyon, France.

Grant Broussard (G)

Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Genetics Curriculum, Chapel Hill, NC 27599, USA.

Ricardo Rivera-Soto (R)

Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Genetics Curriculum, Chapel Hill, NC 27599, USA.

Danielle L Chappell (DL)

Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Ralph S Baric (RS)

Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA; Department of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Blossom Damania (B)

Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA.

Melissa B Miller (MB)

Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Clinical Microbiology Laboratory, UNC Medical Center, Chapel Hill, NC 27599, USA. Electronic address: melissa.miller@unchealth.unc.edu.

Dirk P Dittmer (DP)

Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA. Electronic address: dirkdittmer@me.com.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH